Talk to us

News & activities

Simultaneous assessment of drug mechanisms and infusion reactions

The Immuneed platform is central to a new paper published in International Immunopharmacology. The study explored the donor-specific immune effector signatures of chronic lymphoid lymphoma (CLL) patients in response to anti-CD20 (Rituxi***). On a wider level, however, the study indicates the potential in analyzing multiple mecha...

Meet the Team: Louise - Lab Engineer

As Immuneed’s pool of customers and projects grows, work in the lab is intensifying. Louise Nilsson recently joined the team, so we took a moment to get her thoughts about her new role and workplace.

Introducing our new CEO!

We're pleased to announce that we've appointed Camilla Oldgren as new CEO. Click to read how she will lead the company into the preclinical testing spotlight.